Concepedia

Jasmina Ivanova

JI

35

Publications

1.5K

Citations

21

H-Index

2007

Active since

Affiliations

Analysis Group (United States)(Current)

Eli Lilly (United States)

Pfizer (United States)

Eli Lilly (Germany)

Astellas Pharma (United States)

Jasmina Ivanova is an author at Analysis Group (United States) specializing in public health, health economics, and health services research.

ORCID

Top concepts

Publications per year

2007–2024

35

Publications

35

Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma

Jasmina Ivanova, Rachel Bergman, Howard G. Birnbaum et al. · Journal of Allergy and Clinical Immunology · 2012 · 299 citations

, , +9

Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder

Jasmina Ivanova, Howard G. Birnbaum, Yohanne Kidolezi et al. · Current Medical Research and Opinion · 2010 · 130 citations

Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US

Jasmina Ivanova, Rachel Bergman, Howard G. Birnbaum et al. · Journal of Medical Economics · 2012 · 113 citations · Full text

Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population

Stephen J. Freedland, Matthew M. Davis, Andrew J. Epstein et al. · Prostate Cancer and Prostatic Diseases · 2023 · 90 citations · Full text

Economic Burden of Epilepsy among the Privately Insured in the US

Jasmina Ivanova, Howard G. Birnbaum, Yohanne Kidolezi et al. · PharmacoEconomics · 2010 · 66 citations

, , +13

Rows per page

1–5 of 35